Ventral tegmental area

Last updated
Ventral tegmental area
Gray712.png
Transverse section of mid-brain at level of superior colliculi. (Tegmentum labeled at center right.)
Details
Part of Midbrain
Identifiers
Latin area tegmentalis ventralis
Acronym(s)VTA
MeSH D017557
NeuroNames 521
NeuroLex ID birnlex_1415
Anatomical terms of neuroanatomy

The ventral tegmental area (VTA) (tegmentum is Latin for covering), also known as the ventral tegmental area of Tsai, [1] or simply ventral tegmentum, is a group of neurons located close to the midline on the floor of the midbrain. The VTA is the origin of the dopaminergic cell bodies of the mesocorticolimbic dopamine system and other dopamine pathways; it is widely implicated in the drug and natural reward circuitry of the brain. The VTA plays an important role in a number of processes, including reward cognition (motivational salience, associative learning, and positively-valenced emotions) and orgasm, [2] among others, as well as several psychiatric disorders. Neurons in the VTA project to numerous areas of the brain, ranging from the prefrontal cortex to the caudal brainstem and several regions in between.

Contents

Structure

Anatomical location of VTA in humans Dopamine Pathways.png
Anatomical location of VTA in humans

Neurobiologists have often had great difficulty distinguishing the VTA in humans and other primate brains from the substantia nigra (SN) and surrounding nuclei. Originally, the ventral tegmental area was designated as a ‘nucleus’, but over time ‘area’ became the more appropriate term used because of the heterogeneous cytoarchitectonic features of the region and the lack of clear borders that separate it from adjacent regions. [3] Because of the selective limbic-related afferents to the VTA, the cells of the VTA are given the designation A10 to differentiate them from surrounding cells. [4]

Location

The ventral tegmental area is in the midbrain between several other major areas, some of which are described here. The mammillary bodies and the posterior hypothalamus, both included in the diencephalon, extend rostrally from the VTA. The red nucleus is situated laterally and oculomotor fibers are situated ventromedially to the VTA. [5] The pons and the hindbrain lie caudally to the VTA. Finally, the substantia nigra is located laterally to the VTA. [6]

Subdivisions

In 1987, Oades identified four primary nuclei in the VTA A10 group of cells: the nucleus paranigralis (Npn), the nucleus parabrachialis pigmentosus (Npbp), the nucleus interfascicularis (Nif), and the nucleus linearis (Nln) caudalis and rostralis. Presently, scientists divide the VTA up into four similar zones that are called the paranigral nucleus (PN), the parabrachial pigmented area (PBP), the parafasciculus retroflexus area (PFR), and the rostromedial tegmental nucleus (RMTg), which approximately adhere to the previous divisions. Some definitions of the VTA also include the midline nuclei (i.e. the interfascicular nucleus, rostral linear nucleus, and central linear nucleus).

The PN and PBP are rich in dopaminergic cells, whereas the other two regions have low densities of these neurons. The PFR and RMTg contain a low density of tyrosine hydroxylase (TH)-positive cell bodies that are small in size and lightly stain; the RMTg is composed mostly of GABAergic cells. On the other hand, the PN and PBP consist mainly of medium to large sized TH-positive cell bodies that stain moderately.

Inputs

Almost all areas receiving projections from the VTA project back to it. Thus, the ventral tegmental area is reciprocally connected with a wide range of structures throughout the brain suggesting that it has a role in the control of function in the phylogenetically newer and highly developed neocortex, as well as that of the phylogenetically older limbic areas.[ citation needed ]

The VTA is a heterogeneous region consisting of a variety of neurons that are characterized by different neurochemical and neurophysiological properties. Therefore, glutamatergic and GABAergic inputs are not exclusively inhibitory nor exclusively excitatory. [7] The VTA receives glutamatergic afferents from the prefrontal cortex, pedunculopontine tegmental nucleus (PPTg), laterodorsal tegmental nucleus, subthalamic nucleus, bed nucleus of the stria terminalis, superior colliculus, periaqueductal gray, lateral habenula, dorsal raphe nucleus, and lateral hypothalamic and preoptic areas. [8] [7] These glutamatergic afferents play a key role in regulating VTA cell firing. When the glutamatergic neurons are activated, the firing rates of the dopamine neurons increase in the VTA and induce burst firing. Studies have shown that these glutamatergic actions in the VTA are critical to the effects of drugs of abuse. In contrast, the tail of the ventral tegmental area (tVTA, a.k.a. the RMTg) projects to the VTA with GABAergic afferents, functioning as a "master brake" for the VTA dopamine pathways. [9] [10]

GABAergic inputs to the VTA also include the nucleus accumbens, ventral pallidum, dorsal raphe nucleus, lateral hypothalamus, periaqueductal gray, bed nucleus of the stria terminalis, and rostromedial tegmental nucleus (RMTg). [7] The lateral habenula can also exert an inhibitory effect on dopaminergic neurons in the VTA by exciting RMTg GABAergic neurons, which is thought to play an important role in reward prediction errors. [11] Subpallidal afferents into the VTA are mainly GABAergic and, thus, inhibitory. [7] [12] There is a substantial pathway from the subpallidal area to the VTA. [12] When this pathway is disinhibited, an increase in the dopamine release in the mesolimbic pathway amplifies locomotor activity.[ medical citation needed ]

There are also cholinergic inputs to the VTA, although less studied than the glutamatergic and GABAergic inputs. Optogenetic studies in mice looking at cholinergic inputs from the pedunculopontine tegmental nucleus (PPTg) and the laterodorsal tegmental nucleus demonstrate that these circuits reinforce the discharge properties of VTA neurons, suggesting a modulatory influence on reward circuits. [13]

Outputs

The two primary efferent fiber projections of the VTA are the mesocortical and the mesolimbic pathways, which correspond to the prefrontal cortex and nucleus accumbens respectively. [14] [15] In addition, experiments in rodents have identified a mesohabenular pathway consisting of VTA neurons that do not release dopamine, but glutamate and GABA. [16] [17] Other VTA projections, which utilize dopamine as their primary neurotransmitter, are listed below. [14]

Development

Because they develop from common embryonic tissue and partly overlap in their projection fields, Dopaminergic cell groups lack clear anatomical boundaries. During the development of the mammalian brain, both substantia nigra (SN) and VTA neurons initially project to the dorsolateral and ventromedial striatum. However, at birth the SN dopaminergic neurons project exclusively into the dorsolateral striatum, and the VTA dopaminergic neurons project solely into the ventromedial striatum. This pruning of connections occurs through the elimination of the unnecessary collaterals.[ citation needed ]

Function

As stated above, the VTA, in particular the VTA dopamine neurons, serve several functions in the reward system, motivation, cognition, and drug addiction, and may be the focus of several psychiatric disorders. The VTA has also been shown to process various types of emotion output from the amygdala, where it may also play a role in avoidance and fear-conditioning. [19] [20] Electrophysiological recordings have demonstrated that VTA neurons respond to novel stimuli, unexpected rewards, and reward-predictive sensory cues. The firing pattern of these cells is consistent with the encoding of a reward expectancy error.

In 2006, MRI studies by Helen Fisher and her research team found and documented various emotional states relating to intense love correlated with activity in the VTA, which may help explain obsessive behaviors of rejected partners, since this is shared by the reward system. Nest sharing behavior is associated with increased V1aR expression in the VTA of newly paired zebra finches. [21] However, V1aR expression was not related to female directed song rates, which may indicate a selective role of vasotocin in the VTA on pair maintenance versus courtship behavior. [21]

Presence of gap junctions

The VTA has been shown to have a large network of GABAergic neurons that are interconnected via gap junctions. This network allows for electrical conduction, which is considerably faster than the chemical conduction of signals between synapses, though less spatially precise. [22]

Neural composition

The VTA, like the substantia nigra, is populated with melanin-pigmented dopaminergic neurons. [23] Recent studies have suggested that dopaminergic neurons comprise 50-60% of all neurons in the VTA, [24] which is contrary to previous evidence that noted 77% of neurons within the VTA to be dopaminergic. [25] In addition, there is a sizable population of GABAergic neurons in the rostromedial tegmental nucleus (RMTg), a functionally distinct brain structure. [9] [10] These GABAergic neurons regulate the firing of their dopaminergic counterparts that send projections throughout the brain to, but not limited to, the following regions: the prefrontal cortex, the nucleus accumbens, and the locus coeruleus. The VTA also contains a small percentage of excitatory glutamatergic neurons.

Limbic loop

The “limbic loop” is very similar to the direct pathway motor loop of the basal ganglia. In both systems, there are major excitatory inputs from the cortex to the striatum (accumbens nucleus), the midbrain projects neuromodulatory dopamine neurons to the striatum, the striatum makes internuclear connections to the pallidum, and the pallidum has outputs to the thalamus, which projects to the cortex, thus completing the loop. The limbic loop is distinguished from the motor loop by the source and nature of the cortical input, the division of the striatum and pallidum that process the input, the source of the dopaminergic neurons from the midbrain, and the thalamic target of the pallidal output. The limbic loop controls cognitive and affective functioning and the motor loop controls movement.

CA3 loop

Linking context to reward is important for reward seeking. In 2011, a group of researchers documented a CA3-VTA connection that uses the lateral septum as an intermediary. They used a pseudo-rabies virus (PRV) as a transsynaptic tracer, and injected it into the VTA. They found that unilateral injection into the VTA resulted in bilateral PRV labeling in CA3 beginning 48 hours after injection. Lesions of the caudodorsal lateral septum (cd-LS) before VTA PRV injection resulted in significantly less PRV labeled neurons in CA3. Theta wave stimulation of CA3 resulted in increased firing rates for dopamine cells in the VTA, and decreased firing rates for GABA neurons in the VTA. The identity of VTA neurons was confirmed by neurobiotin™ labeling of the recording neuron, and then histological staining for tyrosine hydroxylase (TH). Temporary inactivation of CA3 via GABA agonists prevented context induced reinstatement of lever pressing for intravenous cocaine. [26]

The authors propose a functional circuit loop where activation of glutamatergic cells in CA3 causes activation of GABAergic cells in cd-LS, which inhibits GABA interneurons in the VTA, releasing the dopamine cells from the tonic inhibition, and leading to an increased firing rate for the dopamine cells. [26]

Reward system

The dopamine reward circuitry in the human brain involves two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. First, the posteromedial VTA and central linear raphe cells selectively project to the ventromedial striatum, which includes the medial olfactory tubercle and the medial NAC shell. Second, the lateral VTA projects largely to the ventrolateral striatum, which includes the NAC core, the medial NAC shell, and the lateral olfactory tubercle. These pathways are called the meso-ventromedial and the meso-ventrolateral striatal dopamine systems, respectively. The medial projection system is important in the regulation of arousal characterized by affect and drive and plays a different role in goal-directed behavior than the lateral projection system. Unlike the lateral part, the medial one is activated not by rewarding but by noxious stimuli. [27] [28] Therefore, the NAC shell and the posterior VTA are the primary areas involved in the reward system.[ citation needed ]

Clinical significance

Disorders

The dopaminergic neurons of the substantia nigra and the ventral tegmental area of the midbrain project to the dorsolateral caudate/putamen and to the ventromedially located nucleus accumbens, respectively, establishing the mesostriatal and the mesolimbic pathways. The close proximity of these two pathways causes them to be grouped together under dopaminergic projections. Several disorders result from the disruption of these two pathways: schizophrenia, Parkinson's disease, and attention deficit hyperactivity disorder (ADHD). Current research is examining the subtle difference between the neurons that are involved in these conditions and trying to find a way to selectively treat a specific dopamine projection.

Drug addiction

The nucleus accumbens and the ventral tegmental area are the primary sites where addictive drugs act. The following are commonly considered to be addictive: cocaine, alcohol, opioids, nicotine, cannabinoids, amphetamine, and their analogs. These drugs alter the neuromodulatory influence of dopamine on the processing of reinforcement signals by prolonging the action of dopamine in the nucleus accumbens or by stimulating the activation of neurons there and also in the VTA. The most common drugs of abuse stimulate the release of dopamine, which creates both their rewarding and the psychomotor effects. Compulsive drug-taking behaviors are a result of the long-lasting or permanent [29] [30] functional changes in the mesolimbic dopamine system arising from repetitive dopamine stimulation. Molecular and cellular adaptations are responsible for a sensitized dopamine activity in the VTA and along the mesolimbic dopamine projection in response to drug abuse. In the VTA of addicted individuals, the activity of the dopamine-synthesizing enzyme tyrosine hydroxylase increases, as does the ability of these neurons to respond to excitatory inputs. The latter effect is secondary to increases in the activity of the transcription factor CREB and the up regulation of GluR1, an important subunit of AMPA receptors for glutamate. These alterations in neural processing could account for the waning influence of adaptive emotional signals in the operation of decision making faculties as drug-seeking and drug-taking behaviors become habitual and compulsive.

Experiments in rats have shown that they learn to press a lever for the administration of stimulant drugs into the posterior VTA more readily than into the anterior VTA. Other studies have shown that microinjections of dopaminergic drugs into the nucleus accumbens shell increase locomotor activity and exploratory behaviors, conditioned approach responses, and anticipatory sexual behaviors.

The withdrawal phenomenon occurs because the deficit in reward functioning initiates a distress cycle wherein the drugs become necessary to restore the normal homeostatic state. Recent research has shown that even after the final stages of withdrawal have been passed, drug-seeking behavior can be restored if exposed to the drug or drug-related stimuli. [31] [32] [33]

Comparative anatomy and evolution

All studies since 1964 have emphasized the impressive general similarity between the VTA of all mammals from rodents to humans. These studies have focused their efforts on rats, rabbits, dogs, cats, opossum, non-human primates, and humans. There have been slight differences noted, such as changes in the dorsal extent of the A10 cells. To be specific, the dorsal peak of A10 cells is more extensive in primates when compared to other mammals. Furthermore, the number of dopaminergic cells in the VTA increases with phylogenetic progression; for instance, the VTA of the mouse contains approximately 25,000 neurons, while the VTA of a 33-year-old man contains around 450,000 cell bodies. [34]

See also

Related Research Articles

<span class="mw-page-title-main">Neurotransmitter</span> Chemical substance that enables neurotransmission

A neurotransmitter is a signaling molecule secreted by a neuron to affect another cell across a synapse. The cell receiving the signal, or target cell, may be another neuron, but could also be a gland or muscle cell.

<span class="mw-page-title-main">Striatum</span> Nucleus in the basal ganglia of the brain

The striatum or corpus striatum is a nucleus in the subcortical basal ganglia of the forebrain. The striatum is a critical component of the motor and reward systems; receives glutamatergic and dopaminergic inputs from different sources; and serves as the primary input to the rest of the basal ganglia.

<span class="mw-page-title-main">Substantia nigra</span> Structure in the basal ganglia of the brain

The substantia nigra (SN) is a basal ganglia structure located in the midbrain that plays an important role in reward and movement. Substantia nigra is Latin for "black substance", reflecting the fact that parts of the substantia nigra appear darker than neighboring areas due to high levels of neuromelanin in dopaminergic neurons. Parkinson's disease is characterized by the loss of dopaminergic neurons in the substantia nigra pars compacta.

<span class="mw-page-title-main">Dopamine</span> Organic chemical that functions both as a hormone and a neurotransmitter

Dopamine is a neuromodulatory molecule that plays several important roles in cells. It is an organic chemical of the catecholamine and phenethylamine families. Dopamine constitutes about 80% of the catecholamine content in the brain. It is an amine synthesized by removing a carboxyl group from a molecule of its precursor chemical, L-DOPA, which is synthesized in the brain and kidneys. Dopamine is also synthesized in plants and most animals. In the brain, dopamine functions as a neurotransmitter—a chemical released by neurons to send signals to other nerve cells. Neurotransmitters are synthesized in specific regions of the brain, but affect many regions systemically. The brain includes several distinct dopamine pathways, one of which plays a major role in the motivational component of reward-motivated behavior. The anticipation of most types of rewards increases the level of dopamine in the brain, and many addictive drugs increase dopamine release or block its reuptake into neurons following release. Other brain dopamine pathways are involved in motor control and in controlling the release of various hormones. These pathways and cell groups form a dopamine system which is neuromodulatory.

<span class="mw-page-title-main">Basal ganglia</span> Group of subcortical nuclei involved in the motor and reward systems

The basal ganglia (BG) or basal nuclei are a group of subcortical nuclei found in the brains of vertebrates. In humans and other primates, differences exist, primarily in the division of the globus pallidus into external and internal regions, and in the division of the striatum. Positioned at the base of the forebrain and the top of the midbrain, they have strong connections with the cerebral cortex, thalamus, brainstem and other brain areas. The basal ganglia are associated with a variety of functions, including regulating voluntary motor movements, procedural learning, habit formation, conditional learning, eye movements, cognition, and emotion.

The mesolimbic pathway, sometimes referred to as the reward pathway, is a dopaminergic pathway in the brain. The pathway connects the ventral tegmental area in the midbrain to the ventral striatum of the basal ganglia in the forebrain. The ventral striatum includes the nucleus accumbens and the olfactory tubercle.

<span class="mw-page-title-main">Nucleus accumbens</span> Region of the basal forebrain

The nucleus accumbens is a region in the basal forebrain rostral to the preoptic area of the hypothalamus. The nucleus accumbens and the olfactory tubercle collectively form the ventral striatum. The ventral striatum and dorsal striatum collectively form the striatum, which is the main component of the basal ganglia. The dopaminergic neurons of the mesolimbic pathway project onto the GABAergic medium spiny neurons of the nucleus accumbens and olfactory tubercle. Each cerebral hemisphere has its own nucleus accumbens, which can be divided into two structures: the nucleus accumbens core and the nucleus accumbens shell. These substructures have different morphology and functions.

<span class="mw-page-title-main">Dopaminergic pathways</span> Projection neurons in the brain that synthesize and release dopamine

Dopaminergic pathways in the human brain are involved in both physiological and behavioral processes including movement, cognition, executive functions, reward, motivation, and neuroendocrine control. Each pathway is a set of projection neurons, consisting of individual dopaminergic neurons.

<span class="mw-page-title-main">Nigrostriatal pathway</span> Bilateral pathway in the brain

The nigrostriatal pathway is a bilateral dopaminergic pathway in the brain that connects the substantia nigra pars compacta (SNc) in the midbrain with the dorsal striatum in the forebrain. It is one of the four major dopamine pathways in the brain, and is critical in the production of movement as part of a system called the basal ganglia motor loop. Dopaminergic neurons of this pathway release dopamine from axon terminals that synapse onto GABAergic medium spiny neurons (MSNs), also known as spiny projection neurons (SPNs), located in the striatum.

Motivational salience is a cognitive process and a form of attention that motivates or propels an individual's behavior towards or away from a particular object, perceived event or outcome. Motivational salience regulates the intensity of behaviors that facilitate the attainment of a particular goal, the amount of time and energy that an individual is willing to expend to attain a particular goal, and the amount of risk that an individual is willing to accept while working to attain a particular goal.

<span class="mw-page-title-main">Reticular formation</span> Spinal trigeminal nucleus

The reticular formation is a set of interconnected nuclei that are located throughout the brainstem. It is not anatomically well defined, because it includes neurons located in different parts of the brain. The neurons of the reticular formation make up a complex set of networks in the core of the brainstem that extend from the upper part of the midbrain to the lower part of the medulla oblongata. The reticular formation includes ascending pathways to the cortex in the ascending reticular activating system (ARAS) and descending pathways to the spinal cord via the reticulospinal tracts.

<span class="mw-page-title-main">Olfactory tubercle</span> Area at the bottom of the forebrain

The olfactory tubercle (OT), also known as the tuberculum olfactorium, is a multi-sensory processing center that is contained within the olfactory cortex and ventral striatum and plays a role in reward cognition. The OT has also been shown to play a role in locomotor and attentional behaviors, particularly in relation to social and sensory responsiveness, and it may be necessary for behavioral flexibility. The OT is interconnected with numerous brain regions, especially the sensory, arousal, and reward centers, thus making it a potentially critical interface between processing of sensory information and the subsequent behavioral responses.

<span class="mw-page-title-main">Medial forebrain bundle</span>

The medial forebrain bundle (MFB) is a neural pathway containing fibers from the basal olfactory regions, the periamygdaloid region and the septal nuclei, as well as fibers from brainstem regions, including the ventral tegmental area and nigrostriatal pathway.

<span class="mw-page-title-main">Medium spiny neuron</span> Type of GABAergic neuron in the striatum

Medium spiny neurons (MSNs), also known as spiny projection neurons (SPNs), are a special type of GABAergic inhibitory cell representing 95% of neurons within the human striatum, a basal ganglia structure. Medium spiny neurons have two primary phenotypes : D1-type MSNs of the direct pathway and D2-type MSNs of the indirect pathway. Most striatal MSNs contain only D1-type or D2-type dopamine receptors, but a subpopulation of MSNs exhibit both phenotypes.

<span class="mw-page-title-main">Reward system</span> Group of neural structures responsible for motivation and desire

The reward system is a group of neural structures responsible for incentive salience, associative learning, and positively-valenced emotions, particularly ones involving pleasure as a core component. Reward is the attractive and motivational property of a stimulus that induces appetitive behavior, also known as approach behavior, and consummatory behavior. A rewarding stimulus has been described as "any stimulus, object, event, activity, or situation that has the potential to make us approach and consume it is by definition a reward". In operant conditioning, rewarding stimuli function as positive reinforcers; however, the converse statement also holds true: positive reinforcers are rewarding.

The ventral pallidum (VP) is a structure within the basal ganglia of the brain. It is an output nucleus whose fibres project to thalamic nuclei, such as the ventral anterior nucleus, the ventral lateral nucleus, and the medial dorsal nucleus. The VP is a core component of the reward system which forms part of the limbic loop of the basal ganglia, a pathway involved in the regulation of motivational salience, behavior, and emotions. It is involved in addiction.

Addiction is a state characterized by compulsive engagement in rewarding stimuli, despite adverse consequences. The process of developing an addiction occurs through instrumental learning, which is otherwise known as operant conditioning.

The rostromedial tegmental nucleus (RMTg), also known as the tail of the ventral tegmental area (tVTA), is a GABAergic nucleus which functions as a "master brake" for the midbrain dopamine system. This region was discovered by the researchers, M. Barrot, J.Kaufling and T. Jhou. It is poorly differentiated from the rest of the ventral tegmental area (VTA) and possesses robust functional and structural links to the dopamine pathways. Notably, both acute and chronic exposure to psychostimulants have been shown to induce FosB and ΔFosB expression in the RMTg; no other drug type has been shown to induce these proteins in the RMTg.

The parafacial zone (PZ) is a brain structure located in the brainstem within the medulla oblongata believed to be heavily responsible for non-rapid eye movement (non-REM) sleep regulation, specifically for inducing slow-wave sleep.

Ilana B. Witten is an American neuroscientist and professor of psychology and neuroscience at Princeton University. Witten studies the mesolimbic pathway, with a focus on the striatal neural circuit mechanisms driving reward learning and decision making.

References

  1. Phillipson OT (September 1979). "Afferent projections to the ventral tegmental area of Tsai and interfascicular nucleus: a horseradish peroxidase study in the rat". The Journal of Comparative Neurology. 187 (1): 117–43. doi:10.1002/cne.901870108. PMID   489776. S2CID   38687887.
  2. Holstege G, Georgiadis JR, Paans AM, Meiners LC, van der Graaf FH, Reinders AA (October 2003). "Brain activation during human male ejaculation". The Journal of Neuroscience. 23 (27): 9185–93. doi:10.1523/JNEUROSCI.23-27-09185.2003. PMC   6740826 . PMID   14534252.
  3. Trutti, Anne C.; Mulder, Martijn J.; Hommel, Bernhard; Forstmann, Birte U. (2019). "Functional neuroanatomical review of the ventral tegmental area". NeuroImage. 191: 258–268. doi:10.1016/j.neuroimage.2019.01.062. hdl: 1887/72460 . ISSN   1053-8119. PMID   30710678. S2CID   72333763.
  4. Björklund, Anders; Dunnett, Stephen B. (May 2007). "Dopamine neuron systems in the brain: an update". Trends in Neurosciences. 30 (5): 194–202. doi:10.1016/j.tins.2007.03.006. ISSN   0166-2236. PMID   17408759. S2CID   14239716.
  5. Vitošević, Z.; Marinković, S.; Cetković, M.; Stimec, B.; Todorović, V.; Kanjuh, V.; Milisavljević, M. (2013). "Intramesencephalic course of the oculomotor nerve fibers: microanatomy and possible clinical significance | SpringerLink". Anatomical Science International. 88 (2): 70–82. doi:10.1007/s12565-012-0166-6. PMID   23242853. S2CID   25783211.
  6. Coenen, Volker Arnd; Schumacher, Lena Valerie; Kaller, Christoph; Schlaepfer, Thomas Eduard; Reinacher, Peter Christoph; Egger, Karl; Urbach, Horst; Reisert, Marco (2018-01-01). "The anatomy of the human medial forebrain bundle: Ventral tegmental area connections to reward-associated subcortical and frontal lobe regions". NeuroImage: Clinical. 18: 770–783. doi:10.1016/j.nicl.2018.03.019. ISSN   2213-1582. PMC   5964495 . PMID   29845013.
  7. 1 2 3 4 Morales, Marisela; Margolis, Elyssa B. (2017-02-01). "Ventral tegmental area: cellular heterogeneity, connectivity and behaviour". Nature Reviews Neuroscience. 18 (2): 73–85. doi:10.1038/nrn.2016.165. ISSN   1471-0048. PMID   28053327. S2CID   10311562.
  8. Morikawa H, Paladini CA (December 2011). "Dynamic regulation of midbrain dopamine neuron activity: intrinsic, synaptic, and plasticity mechanisms". Neuroscience. 198: 95–111. doi:10.1016/j.neuroscience.2011.08.023. PMC   3221882 . PMID   21872647.
  9. 1 2 Bourdy R, Barrot M (November 2012). "A new control center for dopaminergic systems: pulling the VTA by the tail". Trends in Neurosciences. 35 (11): 681–90. doi:10.1016/j.tins.2012.06.007. PMID   22824232. S2CID   43434322. In light of the crucial role of the tVTA in the opiate control of dopamine activity ...
    In the context of addiction, the tVTA is a target for psychostimulant-induced plasticity [1,6,23] and is also essential for morphine action on dopamine neurons [19]. This latter finding suggests that the classical disinhibition model may need to be revisited in light of the GABAergic control that the tVTA exerts on dopamine systems. ...
    The tVTA is rich in inhibitory GABA neurons expressing μ-opioid receptors and sends extensive projections toward midbrain dopamine cells. It is proposed as a major brake for dopamine systems. ...
    The tVTA was initially described in rats as a bilateral cluster of GABA neurons within the posterior VTA, dorsolateral to the interpeduncular nucleus, and expressing FosB/ΔFosB after psychostimulant administration [1]. However, the Fos staining showed that this group of cells extends caudally beyond the defined borders of the VTA [1], shifting dorsally to become embedded within the superior cerebellar peduncle [2]. Around the same time as the tVTA was described, a region caudal to the rat VTA and lateral to the median raphe was proposed to influence passive aversive responses [24]. This region belongs to the reticular formation and was later designated as RMTg [3]. The RMTg extends rostrally, shifting ventrally to become embedded within the posterior VTA. A similar region has also been observed in primates [18] and in mice [25]. There is now agreement that the tVTA and RMTg are two faces of the same structure.
  10. 1 2 Barrot M, Sesack SR, Georges F, Pistis M, Hong S, Jhou TC (October 2012). "Braking dopamine systems: a new GABA master structure for mesolimbic and nigrostriatal functions". The Journal of Neuroscience. 32 (41): 14094–101. doi:10.1523/JNEUROSCI.3370-12.2012. PMC   3513755 . PMID   23055478. The tVTA/RMTg sends dense GABA projections to VTA and substantia nigra neurons. ...
    Indeed, tVTA/RMTg cells express high levels of mu-opioid receptors (Jhou et al., 2009a, 2012; Jalabert et al., 2011), and in vivo, ex vivo and optogenetic electrophysiological approaches demonstrated that morphine excites dopamine neurons by targeting receptors localized to tVTA/RMTg cell bodies as well as its terminals within the VTA (Jalabert et al., 2011; Lecca et al., 2011; Matsui and Williams, 2011; Lecca et al., 2012). ... Recent research on the tVTA/RMTg started from observations related to psychostimulant induction of FosB/ΔFosB (Perrotti et al., 2005) and to the control of aversive responses (Jhou, 2005). The rat tVTA/RMTg showed a neuroanatomically delimited increase in the expression of Fos-related proteins following exposure to psychostimulants (Scammel et al., 2000; Perrotti et al., 2005; Geisler et al., 2008; Jhou et al., 2009a; Kaufling et al., 2009, 2010a, 2010b; Rottlant et al., 2010; Zahm et al., 2010; Cornish et al., 2012). This induction was observed with both acute and chronic exposure to psychostimulants, and with both self-administration and non-contingent administration. There is a strong selectivity of this molecular response, as the Fos-related induction was never observed with non-psychostimulant drugs (Perrotti et al., 2005; Kaufling et al., 2010b).
  11. Watabe-Uchida M, Eshel N, Uchida N (July 2017). "Neural Circuitry of Reward Prediction Error". Annual Review of Neuroscience. 40: 373–394. doi:10.1146/annurev-neuro-072116-031109. PMC   6721851 . PMID   28441114.
  12. 1 2 Wu, Michael; Hrycyshyn, Alan W.; Brudzynski, Stefan M. (1996-11-18). "Subpallidal outputs to the nucleus accumbens and the ventral tegmental area: anatomical and electrophysiological studies". Brain Research. 740 (1): 151–161. doi:10.1016/S0006-8993(96)00859-1. ISSN   0006-8993. PMID   8973809. S2CID   44512008 . Retrieved 2020-10-04.
  13. Dautan, Daniel; Souza, Albert S.; Huerta-Ocampo, Icnelia; Valencia, Miguel; Assous, Maxime; Witten, Ilana B.; Deisseroth, Karl; Tepper, James M.; Bolam, J. Paul; Gerdjikov, Todor V.; Mena-Segovia, Juan (2016). "Segregated cholinergic transmission modulates dopamine neurons integrated in distinct functional circuits". Nature Neuroscience. 19 (8): 1025–1033. doi:10.1038/nn.4335. ISSN   1546-1726. PMC   5086413 . PMID   27348215.
  14. 1 2 3 Malenka RC, Nestler EJ, Hyman SE (2009). "Chapter 6: Widely Projecting Systems: Monoamines, Acetylcholine, and Orexin". In Sydor A, Brown RY (eds.). Molecular Neuropharmacology: A Foundation for Clinical Neuroscience (2nd ed.). New York: McGraw-Hill Medical. pp. 147–148, 154–157. ISBN   9780071481274. Neurons from the SNc densely innervate the dorsal striatum where they play a critical role in the learning and execution of motor programs. Neurons from the VTA innervate the ventral striatum (nucleus accumbens), olfactory bulb, amygdala, hippocampus, orbital and medial prefrontal cortex, and cingulate cortex. VTA DA neurons play a critical role in motivation, reward-related behavior, attention, and multiple forms of memory. ... Thus, acting in diverse terminal fields, dopamine confers motivational salience ("wanting") on the reward itself or associated cues (nucleus accumbens shell region), updates the value placed on different goals in light of this new experience (orbital prefrontal cortex), helps consolidate multiple forms of memory (amygdala and hippocampus), and encodes new motor programs that will facilitate obtaining this reward in the future (nucleus accumbens core region and dorsal striatum). ... DA has multiple actions in the prefrontal cortex. It promotes the "cognitive control" of behavior: the selection and successful monitoring of behavior to facilitate attainment of chosen goals. Aspects of cognitive control in which DA plays a role include working memory, the ability to hold information "on line" in order to guide actions, suppression of prepotent behaviors that compete with goal-directed actions, and control of attention and thus the ability to overcome distractions. ... Noradrenergic projections from the LC thus interact with dopaminergic projections from the VTA to regulate cognitive control. ...
  15. Nechifor M (March 2008). "Magnesium in drug dependences". Magnesium Research. 21 (1): 5–15. doi:10.1684/mrh.2008.0124 (inactive 31 January 2024). PMID   18557129.{{cite journal}}: CS1 maint: DOI inactive as of January 2024 (link)
  16. Stamatakis, Alice M.; Jennings, Joshua H.; Ung, Randall L.; Blair, Grace A.; Weinberg, Richard J.; Neve, Rachael L.; Boyce, Frederick; Mattis, Joanna; Ramakrishnan, Charu; Deisseroth, Karl; Stuber, Garret D. (2013-11-20). "A Unique Population of Ventral Tegmental Area Neurons Inhibits the Lateral Habenula to Promote Reward". Neuron. 80 (4): 1039–1053. doi:10.1016/j.neuron.2013.08.023. ISSN   0896-6273. PMC   3873746 . PMID   24267654.
  17. Root, David H.; Mejias-Aponte, Carlos A.; Zhang, Shiliang; Wang, Hui-Ling; Hoffman, Alexander F.; Lupica, Carl R.; Morales, Marisela (November 2014). "Single rodent mesohabenular axons release glutamate and GABA". Nature Neuroscience. 17 (11): 1543–1551. doi:10.1038/nn.3823. ISSN   1546-1726. PMC   4843828 . PMID   25242304.
  18. Mingote S, Chuhma N, Kusnoor SV, Field B, Deutch AY, Rayport S (December 2015). "Functional Connectome Analysis of Dopamine Neuron Glutamatergic Connections in Forebrain Regions". The Journal of Neuroscience. 35 (49): 16259–71. doi:10.1523/JNEUROSCI.1674-15.2015. PMC   4682788 . PMID   26658874.
  19. 1 2 Tang W, Kochubey O, Kintscher M, Schneggenburger R (April 2020). "A VTA to basal amygdala dopamine projection contributes to signal salient somatosensory events during fear learning". The Journal of Neuroscience. 40 (20): JN–RM–1796-19. doi:10.1523/JNEUROSCI.1796-19.2020. PMC   7219297 . PMID   32277045.
  20. Fadok JP, Dickerson TM, Palmiter RD (September 2009). "Dopamine is necessary for cue-dependent fear conditioning". The Journal of Neuroscience. 29 (36): 11089–97. doi:10.1523/JNEUROSCI.1616-09.2009. PMC   2759996 . PMID   19741115.
  21. 1 2 Tomaszycki ML, Richardson KK, Mann KJ (October 2016). "Sex and pairing status explain variations in the activation of nonapeptide receptors in song and motivation regions". Behavioral Neuroscience. 130 (5): 479–89. doi:10.1037/bne0000159. PMID   27504854.
  22. Allison DW, Ohran AJ, Stobbs SH, Mameli M, Valenzuela CF, Sudweeks SN, et al. (July 2006). "Connexin-36 gap junctions mediate electrical coupling between ventral tegmental area GABA neurons". Synapse. 60 (1): 20–31. doi:10.1002/syn.20272. PMID   16575850. S2CID   4576603.
  23. "Info" (PDF). cogprints.org. Retrieved 2019-12-24.
  24. Margolis EB, Lock H, Hjelmstad GO, Fields HL (December 2006). "The ventral tegmental area revisited: is there an electrophysiological marker for dopaminergic neurons?". The Journal of Physiology. 577 (Pt 3): 907–24. doi:10.1113/jphysiol.2006.117069. PMC   1890372 . PMID   16959856.
  25. Johnson SW, North RA (May 1992). "Two types of neurone in the rat ventral tegmental area and their synaptic inputs". The Journal of Physiology. 450: 455–68. doi:10.1113/jphysiol.1992.sp019136. PMC   1176131 . PMID   1331427.
  26. 1 2 Luo AH, Tahsili-Fahadan P, Wise RA, Lupica CR, Aston-Jones G (July 2011). "Linking context with reward: a functional circuit from hippocampal CA3 to ventral tegmental area". Science. 333 (6040): 353–7. Bibcode:2011Sci...333..353L. doi:10.1126/science.1204622. PMC   3150711 . PMID   21764750.
  27. Ikemoto S (November 2007). "Dopamine reward circuitry: two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex". Brain Research Reviews. 56 (1): 27–78. doi:10.1016/j.brainresrev.2007.05.004. PMC   2134972 . PMID   17574681.
  28. Brischoux F, Chakraborty S, Brierley DI, Ungless MA (March 2009). "Phasic excitation of dopamine neurons in ventral VTA by noxious stimuli". Proceedings of the National Academy of Sciences of the United States of America. 106 (12): 4894–9. Bibcode:2009PNAS..106.4894B. doi: 10.1073/pnas.0811507106 . PMC   2660746 . PMID   19261850.
  29. Powledge, Tabitha M. (1999). "Addiction and the brain". BioScience. 49 (7): 513–519. doi:10.2307/1313471. ISSN   1525-3244. JSTOR   1313471.
  30. Bechara, Antoine; Berridge, Kent C.; Bickel, Warren K.; Morón, Jose A.; Williams, Sidney B.; Stein, Jeffrey S. (2019). "A Neurobehavioral Approach to Addiction: Implications for the Opioid Epidemic and the Psychology of Addiction". Psychological Science in the Public Interest. 20 (2): 96–127. doi:10.1177/1529100619860513. ISSN   1529-1006. PMC   7001788 . PMID   31591935.
  31. Fuchs, R.A.; Lasseter, H.C.; Ramirez, D.R.; Xie, X. (2008). "Relapse to drug seeking following prolonged abstinence: the role of environmental stimuli". Drug Discovery Today. Disease Models. 5 (4): 251–258. doi:10.1016/j.ddmod.2009.03.001. ISSN   1740-6757. PMC   2794206 . PMID   20016771.
  32. Sinha, Rajita (2008). "Chronic Stress, Drug Use, and Vulnerability to Addiction". Annals of the New York Academy of Sciences. 1141: 105–130. doi:10.1196/annals.1441.030. ISSN   0077-8923. PMC   2732004 . PMID   18991954.
  33. Koob, George F.; Volkow, Nora D. (2010). "Neurocircuitry of Addiction". Neuropsychopharmacology. 35 (1): 217–238. doi:10.1038/npp.2009.110. ISSN   1740-634X. PMC   2805560 . PMID   19710631.
  34. Oades RD, Halliday GM (May 1987). "Ventral tegmental (A10) system: neurobiology. 1. Anatomy and connectivity" (PDF). Brain Research. 434 (2): 117–65. doi:10.1016/0165-0173(87)90011-7. PMID   3107759. S2CID   20438553.

Further reading